Here are five observations:
1. The shift to outpatient spine surgery serves as the ultimate boost for the spinal implants market.
2. The increasing number of non-fusion spinal procedures will also spur market growth.
3. With the growing popularity of non-fusion procedures, many companies have started developing devices for artificial disc replacement, dynamic stabilization and interspinous process decompression.
4. Spinal implant-associated complications could hinder market growth.
5. DePuy Synthes, Medtronic, NuVasive, Stryker and Zimmer Biomet lead the market.
More articles on devices:
St. Mary’s Medical Center surgeons complete 100th Mazor robotic spine surgery: 3 highlights
Avitus Orthopaedics launches Avitus Bone Harvester — 5 highlights
Top 5 vendors in global sports medicine market: Stryker, DePuy Synthes & more
